BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6795552)

  • 1. Restoration of the ovarian response to gonadotropins in patients after molar abortion.
    Miyake A; Aono T; Kurachi H; Tsutsumi H; Kurachi K
    Obstet Gynecol; 1981 Nov; 58(5):566-8. PubMed ID: 6795552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum 17beta-estradiol. Index of follicular maturation during gonadotropin therapy.
    Notation AD; Tagatz GE; Steffes MW
    Obstet Gynecol; 1978 Feb; 51(2):204-9. PubMed ID: 622235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of the gonadotrophin response to LH-RH and oestrogen administration in patients after molar abortion.
    Miyake A; Aono T; Tanizawa O; Kurachi H; Kurachi K
    Acta Endocrinol (Copenh); 1979 May; 91(1):30-5. PubMed ID: 222100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Luteal phase estradiol and pregnancy outcome in gonadotropin releasing hormone agonist/human menopausal gonadotropin-treated gamete intrafallopian transfer cycles.
    Molo MW; Rawlins RG; Binor Z; Kelly M; Radwanska E
    J Reprod Med; 1995 Jun; 40(6):418-22. PubMed ID: 7650652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum relaxin in patients with hydatidiform mole.
    Seki K; Uesato T; Tabei T; Kato K
    Obstet Gynecol; 1986 Mar; 67(3):381-3. PubMed ID: 3945450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients.
    Smitz J; Andersen AN; Devroey P; Arce JC;
    Hum Reprod; 2007 Mar; 22(3):676-87. PubMed ID: 17110397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CA-125 serum level in early pregnancy follow hMG/hCG stimulated and unstimulated cycles].
    Wilke G; Hinney B; Rath W; Henze C; Wuttke W; Kuhn W
    Geburtshilfe Frauenheilkd; 1990 Dec; 50(12):941-6. PubMed ID: 2128287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancy.
    Wolfberg AJ; Feltmate C; Goldstein DP; Berkowitz RS; Lieberman E
    Obstet Gynecol; 2004 Sep; 104(3):551-4. PubMed ID: 15339768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy.
    Wolfberg AJ; Berkowitz RS; Goldstein DP; Feltmate C; Lieberman E
    Obstet Gynecol; 2005 Sep; 106(3):548-52. PubMed ID: 16135585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing severe ovarian hyperstimulation syndrome in an in vitro fertilization/embryo transfer program. Use of follicular aspiration after human chorionic gonadotropin administration.
    Vrtovec HM; Tomazevic T
    J Reprod Med; 1995 Jan; 40(1):37-40. PubMed ID: 7722973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cocaine impairs ovarian response to exogenous gonadotropins in nonhuman primates.
    Thyer AC; King TS; Moreno AC; Eddy CA; Siler-Khodr TM; Schenken RS
    J Soc Gynecol Investig; 2001; 8(6):358-62. PubMed ID: 11750872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An unusual clinical course after mole evacuation: a case report.
    Okamoto T; Nakanishi T; Nomura S; Goto S; Sakaida H; Tomoda Y
    Nagoya J Med Sci; 1997 Mar; 60(1-2):49-52. PubMed ID: 9212649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
    Franke HR; Risse EK; Kenemans P; Houx PC; Stolk JG; Vooijs GP
    Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid function and human chorionic gonadotropin in patients with hydatidiform mole.
    Ngowngarmratana S; Sunthornthepvarakul T; Kanchanawat S
    J Med Assoc Thai; 1997 Nov; 80(11):693-9. PubMed ID: 9385765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Controlled hyperstimulation in intra-uterine inseminations: hMG-hCG protocol (204 cycles)].
    Abboud P; Delépine B; Pigeon F; Bednarczyk L; Quéreux C
    Contracept Fertil Sex; 1997 Jun; 25(6):463-9. PubMed ID: 9280551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic characteristics of serum human chorionic gonadotropin titer regression following molar pregnancy.
    Schlaerth JB; Morrow CP; Kletzky OA; Nalick RH; D'Ablaing GA
    Obstet Gynecol; 1981 Oct; 58(4):478-82. PubMed ID: 7279342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of growth hormone (GH), GH-receptor and GH-binding protein in reproduction and ovulation induction.
    Blumenfeld Z; Amit T
    J Pediatr Endocrinol Metab; 1996; 9(2):145-62. PubMed ID: 8887137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian response in World Health Organization group II anovulatory women during consecutive human menopausal gonadotropin cycles.
    Fluker MR; Yarali H; Yuen BH
    J Reprod Med; 1993 Nov; 38(11):839-42. PubMed ID: 8277477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled ovarian stimulation with exclusive FSH followed by stimulation with hCG alone, FSH alone or hMG.
    Gomes MK; Vieira CS; Moura MD; Manetta LA; Leite SP; Reis RM; Ferriani RA
    Eur J Obstet Gynecol Reprod Biol; 2007 Jan; 130(1):99-106. PubMed ID: 16835006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgenic response in anovulatory women during menotropins stimulation.
    Skaf RA; Shelden R; Kemmann E
    Obstet Gynecol; 1981 Dec; 58(6):714-9. PubMed ID: 6796920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.